The first Adicet Bio trade was made in Q1 2021.
Since then Steven Cohen bought shares three more times and sold shares on six occasions. The investor sold all their shares in Q2 2023 and doesn't own any shares in Adicet Bio anymore.
Avg closing price
Price range
Sold -17.7 Thousand shares
Q2 2023
Avg closing price
$5.52
Price range
$2.13
-
$7.13
Increased shares by 5786.0% (+17.4 Thousand shares)
Q1 2023
Avg closing price
$7.84
Price range
$5.52
-
$9.23
Sold 99.7% shares (-114 Thousand shares)
Q4 2022
Avg closing price
$15.60
Price range
$7.72
-
$21.27
Sold 8.9% shares (-11.1 Thousand shares)
Q3 2022
Avg closing price
$15.86
Price range
$13.43
-
$18.74
Sold 68.6% shares (-273 Thousand shares)
Q2 2022
Avg closing price
$13.72
Price range
$10.26
-
$20.81
Sold 50.5% shares (-406 Thousand shares)
Q1 2022
Avg closing price
$14.38
Price range
$11.53
-
$19.97
Sold 36.9% shares (-471 Thousand shares)
Q4 2021
Avg closing price
$10.73
Price range
$7.37
-
$17.49
Increased shares by 4.9% (+60 Thousand shares)
Q3 2021
Avg closing price
$7.75
Price range
$6.29
-
$9.93
Increased shares by 15.9% (+167 Thousand shares)
Q2 2021